Product name:Bumetanide
CAS: 28395-03-1
Molecular Formula:C17H20N2O5S
Molecular weight:364.42
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :In the brain, bumetanide blocks the NKCC1 cation-chloride co-transporter, and thus decreases internal chloride concentration in neurons. In turn, this concentration change makes the action of GABA more hyperpolarizing, which may be useful for treatment of neonatal seizures, which quite often are not responsive to traditional GABA-targeted treatment, such as barbiturates. Bumetanide is therefore currently under evaluation as a prospective antiepileptic drug.
2018年9月14日星期五
Meleumycin
Product name:Meleumycin
CAS: 149370-53-6
Molecular Formula: C41H67NO15.C40H65NO15
Molecular weight:1613.92
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :This product is antibiotics.It can be used to treat ENT, Streptococcus, Streptococcus pneumoniae, Staphylococcus aureus and other sensitive Gram-positive bacteria caused by ENT infection, dental infections, respiratory infections, skin and soft tissue infections, including those caused by Pharyngitis, tonsillitis, scarlet fever, erysipelas, lobular pneumonia and so on.
CAS: 149370-53-6
Molecular Formula: C41H67NO15.C40H65NO15
Molecular weight:1613.92
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :This product is antibiotics.It can be used to treat ENT, Streptococcus, Streptococcus pneumoniae, Staphylococcus aureus and other sensitive Gram-positive bacteria caused by ENT infection, dental infections, respiratory infections, skin and soft tissue infections, including those caused by Pharyngitis, tonsillitis, scarlet fever, erysipelas, lobular pneumonia and so on.
Regorafenib
Product name:Regorafenib
CAS: 755037-03-7
Molecular Formula: C21H15ClF4N4O3
Molecular weight:482.815
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.
CAS: 755037-03-7
Molecular Formula: C21H15ClF4N4O3
Molecular weight:482.815
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Regorafenib is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.
Enocitabine
Product name:Enocitabine
CAS: 55726-47-1
Molecular Formula: C31H55N3O6
Molecular weight:565.78
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Enocitabine is a derivative of cytarabine that acts as a nucleoside analog of cytosine. Enocitabine is the a pro-drug of Ara-C and exhibits anticancer chemotherapeutic and antiviral activities. Like other nucleoside analogs, enocitabine is incorporated into DNA, preventing chain elongation and cell growth. Enocitabine is clinically used in some countries and is undergoing clinical trials in others as a potential treatment for leukemias and lymphomas such as acute myelogenous leukemia (AML).
CAS: 55726-47-1
Molecular Formula: C31H55N3O6
Molecular weight:565.78
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Enocitabine is a derivative of cytarabine that acts as a nucleoside analog of cytosine. Enocitabine is the a pro-drug of Ara-C and exhibits anticancer chemotherapeutic and antiviral activities. Like other nucleoside analogs, enocitabine is incorporated into DNA, preventing chain elongation and cell growth. Enocitabine is clinically used in some countries and is undergoing clinical trials in others as a potential treatment for leukemias and lymphomas such as acute myelogenous leukemia (AML).
Ubenimex
Product name:Ubenimex
CAS: 58970-76-6
Molecular Formula: C16H24N2O4
Molecular weight:308.38
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Ubenimex is a competitive, reversible protease inhibitor. It is an inhibitor of arginyl aminopeptidase (aminopeptidase B),leukotriene A4 hydrolase (a zinc metalloprotease that displays both epoxide hydrolase and aminopeptidase activities),alanyl aminopeptidase (aminopeptidase M/N),leucyl/cystinyl aminopeptidase (oxytocinase/vasopressinase),and membrane dipeptidase (leukotriene D4 hydrolase). It is being studied for use in the treatment of acute myelocytic leukemia.
CAS: 58970-76-6
Molecular Formula: C16H24N2O4
Molecular weight:308.38
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Ubenimex is a competitive, reversible protease inhibitor. It is an inhibitor of arginyl aminopeptidase (aminopeptidase B),leukotriene A4 hydrolase (a zinc metalloprotease that displays both epoxide hydrolase and aminopeptidase activities),alanyl aminopeptidase (aminopeptidase M/N),leucyl/cystinyl aminopeptidase (oxytocinase/vasopressinase),and membrane dipeptidase (leukotriene D4 hydrolase). It is being studied for use in the treatment of acute myelocytic leukemia.
Lonidamine
Product name:Lonidamine
CAS: 50264-69-2
Molecular Formula: C15H10Cl2N2O2
Molecular weight:321.1581
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Lonidamine is a derivative of indazole-3-carboxylic acid, which for a long time, has been known to inhibit aerobic glycolysis in cancer cells. It seems to enhance aerobic glycolysis in normal cells, but suppress glycolysis in cancer cells. This is most likely through the inhibition of the mitochondrially bound hexokinase.
CAS: 50264-69-2
Molecular Formula: C15H10Cl2N2O2
Molecular weight:321.1581
Appearance:white powder
Stability:Stable
Shelf life:2 years
Product description :Lonidamine is a derivative of indazole-3-carboxylic acid, which for a long time, has been known to inhibit aerobic glycolysis in cancer cells. It seems to enhance aerobic glycolysis in normal cells, but suppress glycolysis in cancer cells. This is most likely through the inhibition of the mitochondrially bound hexokinase.
订阅：
博文 (Atom)